These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6462008)

  • 21. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles].
    Lévy RH
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical pharmacokinetics of the anti-arrhythmic agent changrolin].
    Chen WZ; Wang CG; Yang XY; Cai NS; Zhu JR
    Yao Xue Xue Bao; 1985 Jul; 20(7):505-8. PubMed ID: 4096242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Determination of nevadensin in specimens and its pharmacokinetic (author's transl)].
    Han GZ; Su CY; Zhang Y
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):182-5. PubMed ID: 6462009
    [No Abstract]   [Full Text] [Related]  

  • 24. Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: application to a bioavailability study.
    Yang D; Yu C; Li S; Liu G; Lu Y; Wang Y
    J Pharm Biomed Anal; 2009 Sep; 50(2):189-93. PubMed ID: 19467818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on antiarrhythmics. I. Synthesis of 3,4,5,-trimethoxybenzamide derivatives (author's transl)].
    Liu YS; Zhou ZS; Gu KJ; Liang CY
    Yao Xue Xue Bao; 1981 Feb; 16(2):158-60. PubMed ID: 7304186
    [No Abstract]   [Full Text] [Related]  

  • 26. [The metabolism of 3H-curcumol in normal rats and tumour bearing mice (author's transl)].
    Su CY; Liu XY; Xu HX; Zhu XY
    Yao Xue Xue Bao; 1980 May; 15(5):257-62. PubMed ID: 7457146
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Organically bound tritium].
    Zhuravlev VF
    Med Radiol (Mosk); 1981 Jun; 26(6):67-71. PubMed ID: 7022086
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alkaloids of Monimia rotundifolia pet.-th.; preparation of laurotetanine derived compounds with antiarrhythmic properties (author's transl)].
    Leboeuf M; Cavé A; Provost J; Tiberghien R; Forgacs P
    Ann Pharm Fr; 1980; 38(6):537-44. PubMed ID: 7283352
    [No Abstract]   [Full Text] [Related]  

  • 31. [The in vivo disposition of diethyllipoamide (author's transl)].
    Xia SX; Xu HY; Chen NQ; Shen BF
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):136-9. PubMed ID: 6214148
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of tetrandrine on experimental arrhythmias [author's transl)].
    Ke J; Weng SA; Zhang GQ; Yang YH; Wang JK; Fu RF
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):235-7. PubMed ID: 6462021
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].
    Albin H; Vincon G; Ploux D; Dangoumau J
    J Pharmacol; 1981; 12(3):229-38. PubMed ID: 7289622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of changrolin on potassium currents in guinea pig and rabbit single heart cells.
    Lü LL
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1015-8. PubMed ID: 11270967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue distribution of [3H]centpiperalone after oral administration.
    Mukerjee SS; Dey S; Bhaduri AP; Mukherjee SK
    Indian J Biochem Biophys; 1980 Oct; 17(5):399-401. PubMed ID: 7251022
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys.
    Konishi T; Okada S; Nishikawa H; Esumi Y; Kitamura S; Tatsumi K
    Arzneimittelforschung; 1998 Mar; 48(3):266-74. PubMed ID: 9553685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy of malignant brain tumors: biology and pharmacokinetics (author's transl)].
    Hoshino T
    No Shinkei Geka; 1980 Nov; 8(11):1007-16. PubMed ID: 7005704
    [No Abstract]   [Full Text] [Related]  

  • 40. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.